2 months Royal Bank of Canada Reiterates “Sector Perform” Rating for BioMarin Pharmaceutical (NASDAQ:BMRN) MarketBeat
Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $80.00 price target on shares of BioMarin Pharmaceutical in a research note on Wednesday.
Biomarin Pharma (BMRN) · Canada · Nasdaq 100 · Royal Bank of Canada · Science
X